Format

Send to

Choose Destination
Neuroimaging Clin N Am. 2006 May;16(2):217-28, ix.

3.0 T neuroimaging: technical considerations and clinical applications.

Author information

1
Department of Radiology, University of Bonn, Sigmund-Freud-Strasse 25, D-53105 Bonn, Germany. winfried.willinek@ukb.uni-bonn.de

Abstract

Since approval by the US Food and Drug Administration (FDA) in 2000, human MR imaging at field strength up to 4.0 T in clinical practice and up to 8.0 T on research systems has become available. Although human MR imaging at field strengths greater than 1.5 T was performed even before 1999 on research systems, the FDA approval for clinical use and the advent of actively shielded magnets marked a new trend for MR vendors and users. Because of the potential technical benefits when moving from 1.5 T to 3.0 T, the number of 3.0 T installations is increasing continuously worldwide. This article reviews the benefits, challenges, and the current knowledge of 3.0 T whole body MR imaging and summarizes its clinical applications.

PMID:
16731361
DOI:
10.1016/j.nic.2006.02.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center